Category: Healthcare

Why AstraZeneca Can Climb Again When Focusing On This Promising Treatment

AZN

General, HealthcareBy Omar September 2, 2020

AstraZeneca PLC ($AZN) announced remarkable numbers about the Farxiga study that includes positive data for the Phase III. The study result shows a significant decrease in the risk of renal failure, cardiovascular or renal death in patients suffering from chronic kidney disease. Further data from the Phase III DAPA-CKD study showed that Farxiga – in…

Why major pharmaceutical and biotech companies will keep growing for years

GILD

COVID-19, General, HealthcareBy Omar August 31, 2020

Several big pharmaceutical groups are undervalued according to Morningstar: Roche ($RHHBY), Bristol ($BMY), Merck ($MRK) and Pfizer ($PFE). These stocks are expected to grow an average of 5% annually through 2024. The COVID-19 pandemic has so far not had a major negative impact on expected performance. An expected average growth till 2024 The major pharmaceutical…

This is why the Belgian Galapagos is still targeting the US

GLPG

General, HealthcareBy Omar August 31, 2020

The Galapagos ($GLPG) stock price has fallen after the rheumatism drug has not received approval from the FDA earlier this month. There is still the possibility that the drug may soon be used in Europe. What can we expect the coming weeks in September? Rejection calls for new opportunities Galapagos had a great disappointment on…

Update About Moderna After Trump Tightens Targets For A COVID-19 Vaccine

MRNA

COVID-19, General, HealthcareBy Omar August 28, 2020

US biotech company Moderna ($MRNA) is talking with the Japanese health ministry about the supply of 40 million corona vaccines. The company confirmed this Friday afternoon after Japanese minister Kato Katsunobu communicated about this in national media. The vaccine will be supplied by Moderna, while Takeda Pharmaceutical will be responsible for distribution. The company would…

Why Ovid Therapeutics is on the radar of many farmaceutical investors

OVID

General, HealthcareBy Omar August 28, 2020

Ovid Therapeutics ($OVID) a farmaceutical company that focuses on medication for Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS) – two rare and difficult forms of epilepsy with children – noticed a powerful spike with the stock before the promising phase 2 results for a medication called Soticlestat. This medicine is being developed in a 50-50…

How the COVID-19 Vaccine Mania is Most Profitable for Investors

JNJ

COVID-19, General, HealthcareBy Omar August 25, 2020

Breakout Stocks Corona Virus Stocks Since May 2020, the analysts from Swiss bank UBS have noticed an investor optimism over the development of a COVID-19 vaccine that has added about 6.5 percentage points to the returns of the S&P 500. Epidural Proves Deadly In NY Hospital – Milestone Scientific Has Solution . Maxim Group $4.00 Target…

Keep An Eye On Ocugen: What Do The Insiders Know Since They Only Buy Shares

OCGN

General, HealthcareBy Omar August 24, 2020

Breakout Stocks Corona Virus Stocks The purchases and sales of insiders of Ocugen, Inc. (NASDAQ: $OCGN) were reviewed today. Ocugen is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Their modifier gene therapy platform has the potential to treat multiple retinal diseases with one single drug. “Insiders can sell…

Donald Trump Gives iBio Reason to Rejoice, but Caution is Advised

IBIO

COVID-19, General, HealthcareBy Omar August 24, 2020

Breakout Stocks Corona Virus Stocks iBio, Inc. ($IBIO) is once again receiving a lot of attention at the beginning of the week. The outcome, a remarkable increase earlier today of the share with more than 40%. Both the sentiment and message volume are also showing green figures today, resulting in the share being widely discussed on…

Kazia jumps after lead drug is awarded by the FDA

KZIA

General, HealthcareBy Omar August 20, 2020

Exciting news this morning for biotech company Kazia Therapeutics Limited ($KZIA), after the American FDA has awarded Fast Track Designation (FTD) to paxalisib for glioblastoma. Glioblastoma is the most common and aggressive brain cancer treated by Kazia with paxalisib – previously called GDC-0084. With the granting of FTD, the development of the drug can be…

David vs Goliath: Who is Moderna Presenting in the Battle against COVID-19?

MRNA

COVID-19, General, HealthcareBy Omar August 19, 2020

Breakout Stocks Corona Virus Stocks There are currently many different pharmaceutical companies that focus on COVID-19, that it is possible people have lost the overview. One company that has been in the spotlight for quite some time is Moderna ($MRNA). The company, in collaboration with the National Institutes of Health (NIH) and researchers in the COVE…

Category Archives: Healthcare